A.I. IVANOV^{1, 3, 4}, M.V. BURMISTROV^{2, 3, 4}, V.A. POPOV^{2, 3, 4}, S.I. BEBEZOV¹

¹Republican Clinical Oncologic Dispensary of the Ministry of Health of the Republic of Tatarstan, Kazan

²Republican Clinical Hospital of the Ministry of Healthcare of the Republic of Tatarstan, Kazan

³Kazan State Medical Academy – Branch Campus of  RMACPE MH Russia, Kazan

⁴National Medical Research Center for Oncology named after N.N. Blokhin” of the Ministry of Health of Russia, Moscow

 Contact details:

Ivanov A.I. — PhD (medicine), Associate Professor of the Department of Endoscopy, General and Endoscopic Surgery, Head of the Department of Endoscopy

Address: 29 Sibirsky tract St., Kazan, Russian Federation, 420029, tel. +7-917- 261-92-51, e-mail: a.i.ivanov@inbox.ru

 Abstract. Palliative management of inoperable patients with malignant tumors of the esophagus and stomach remains a difficult task and often requires an interdisciplinary approach to achieve optimal effectiveness. Currently, endoscopic stenting has become an established practice in the treatment of malignant esophageal stenosis, improving the quality of life of incurable patients. With the development of many different esophageal stents, recent studies show that esophageal stenting is useful in treating refractory benign dysphagia, and is also effective in achieving separation of esophago-respiratory fistula. The article presents the results of implantation of esophageal stents in 219 patients with malignant stenosis of the esophagus and stomach, as well as malignant esophago-respiratory fistulas. Complications and methods for their endoscopic resolution are considered. Also, own experience of implantation of esophageal stents of various manufacturers is presented. The analysis of life expectancy after stenting in 176 incurable patients with malignant stenosis of the esophagus and stomach was performed. In addition, the article presents the experience of implantation of biodegradable stents in three patients with benign esophageal stenosis.

Key words: stenting, esophageal stent, self-expanding stents, patient life expectancy.

 (For citation: Ivanov A.I., Burmistrov M.V., Popov V.A., Bebezov S.I. Analysis of the results of stenting in patients with benign and malignant stenoses of the esophagus and stomach, as well as esophageal respiratory fistulas. Practical Medicine. 2019). Vol. 17, № 6 (part 2), P. 67-73)

REFERENCES

1. Egan J.U., Baron T.H., Adler D.G. et al. Standards of Practice Committee. Esophageal dilation. Gastrointest Endosc., 2006, vol. 63, pp. 755–760.
2. Parkin D.M., Bray F.I., Deresa S.S. Cancer burden in the year 2000. The global picture. J. Cancer, 2001, vol. 37, pp. 4–66.
3. Pisani P., Parkin D.M., Bray F., Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. J. Cancer, 1999, vol. 83, pp. 18–29.
4. Brierley J.D., Oza A.M. Radiation and chemotherapy in the management of malignant esophageal strictures. Gastrointestinal Endoscopy Clinics of North America, 1998, vol. 8 (2), pp. 451–463.
5. Burt M. Management of malignant esophagorespiratory fistula. Chest Surg. Clin. N Am, 1996, vol. 6, pp. 765–776.
6. Little A.G., Ferguson M.K., DeMeester T.R. et al. Esophageal carcinoma with respiratory tract fistula. Cancer, 1984, vol. 53, pp. 1322–1328.
7. Shin J.H., Kim J.H., Song H.Y. Interventional management of esophagorespiratory fistula. Korean J. Radiol, 2010, vol. 11, pp. 133–140.
8. May A., Ell C. Palliative treatment of malignant esophagorespiratory fistulas with Gianturco-Z stents. A prospective clinical trial and review of the literature on covered metal stents. J. Gastroenterol, 1998, vol. 93, pp. 532–535.
9. Ross W.A., Alkassab F., Lynch P.M. et al. Evolving role of self-expanding metal stents in the treatment of malignant dysphagia and fistulas. Gastrointest Endosc, 2007, vol. 65, pp. 70–76.
10. Repici A., Small A.J., Mendelson A. et al. Natural history and management of refractory benign esophageal strictures. Gastrointest Endosc, 2016, vol. 84 (2), pp. 222–228.
11. Rodrigues-Pinto E., Pereira P., Ribeiro A. et al. Risk factors associated with refractoriness to esophageal dilatation for benign dysphagia. J. Gastroenterol Hepatol, 2016, vol. 28 (6), pp. 684–688.
12. van Boeckel P.G., Siersema P.D. Refractory esophageal strictures: what to do when dilation fails. Curr Treat Options Gastroenterol, 2015, vol. 13 (1), pp. 47–58.
13. Bram D. Vermeulen, Peter D. Siersema. Esophageal Stenting in Clinical Practice: an Overview Curr Treat Options. Gastroenterol, 2018, vol. 16 (2), pp. 260–273.
14. Cusumano A., Ruol A., Segalin A. et al. Push-through intubation: effective palliation in 409 patients with cancer of the esophagus and cardia. Annals of Thoracic Surgery, 1992, vol. 53 (6), pp. 1010–1015.
15. Christie N.A., Buenaventura P.O., Fernando H.C. et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Annals of Thoracic Surgery, 2001, vol. 71 (6), pp. 1797–1802.
16. Parker C.H., Peura D.A. Palliative treatment of esophageal carcinoma using esophageal dilation and prosthesis. Gastroenterology Clinics of North America, 1991, vol. 20 (4), pp. 717–729.
17. Fugger R., Niederle B., Jantsch H. et al. Endoscopic tube implantation for the palliation of malignant esophageal stenosis. Endoscopy, 1990, vol. 22 (3), pp.101–104.
18. Yakoub D., Fahmy R., Athanasiou T. et al. Evidence-based choice of esophageal stent for the palliative management of malignant dysphagia. World Journal of Surgery, 2008, vol. 32 (9), pp. 1996–2009.
19. Knyrim K., Wagner H.J., Bethge N. et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. New England Journal of Medicine, 1993, vol. 329 (18), pp. 1302–1307.
20. Siersema P.D., Hop W.C.J., van Blankenstein M., Dees J. A new design metal stent (Flamingo stent) for palliation of malignant dysphagia: a prospective study. The Rotterdam Esophageal Tumor Study Group. Gastrointestinal Endoscopy, 2000, vol. 51 (2), pp. 139–145.